Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label ERT. Show all posts
Showing posts with label ERT. Show all posts
Tuesday, May 29, 2012

HRT Risk Holds Steady Based on Updated Review - in OB/Gyn, HRT from MedPage Today

›
HRT Risk Holds Steady Based on Updated Review - in OB/Gyn, HRT from MedPage Today Action Points A systematic review of papers publi...
Monday, April 30, 2012

paywalled: Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial : The Lancet Oncology

›
Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the W...

Commentary: Oestrogen and breast cancer: results from the WHI trial : The Lancet Oncology

›
Oestrogen and breast cancer: results from the WHI trial : The Lancet Oncology "In The Lancet Oncology , the Women's Health Initia...
Saturday, April 21, 2012

abstract: Hormone Therapy and Different Ovarian Cancers: A National Cohort Study (postmenopausal women/does not include reference to clear cell ovarian)

›
  Blogger's Note: the abstract makes no reference to clear cell ovarian, given the number of women followed this omission (in the abstr...
Sunday, February 12, 2012

abstract: Chinese Journal of Cancer Research - Attributable causes of breast cancer and ovarian cancer in China: Reproductive factors, oral contraceptives and hormone replacement therapy

›
Abstract Objective To provide an evidence-based, consistent assessment of the burden of breast cancer attributable to reproduc...
Monday, June 13, 2011

press release International Menopause Society - Global expert review confirms that Hormone Replacement Therapy needs to be customised but is safe for most women.

›
Thursday, June 02, 2011

University of Pennsylvania School of Medicine - Women with BRCA mutations can take hormone-replacement therapy safely after ovary removal

›
CHICAGO) –– Women with the BRCA1 or BRCA2 gene mutations, which are linked to a very high risk of breast and ovarian cancer, can safely ...
Saturday, May 21, 2011

abstract: he impact of prophylactic salpingo-oophorectomy on menopausal symptoms and sexual function in women who carry a BRCA mutation

›
Blogger's Note : this study would apply to all those who experience surgical menopause including those eg. Lynch Syndrome/other Syndrom...
Saturday, March 26, 2011

Risk assessment for recurrent venous thrombosis – The Lancet (as it applies to transdermal oestrogens)

›
Note:   author's response to commentaries on the original research article,  links  included to the discussion
Friday, August 13, 2010

Caveats and Concerns With New Study on Hormone Therapy and Breast Cancer

›
Note: references studies - WHI (Women's Health Initiative) and California Teachers Study Clinicians vary in their approaches to HT, ...
Wednesday, January 27, 2010

(financial news source) Non-Patch, Transdermal Estrogen Products Such as Divigel(R) Are Effective Hormone Therapy Alternatives to Oral Estrogen

›